MedTrace Logo

Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts

NCT05324904 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-04-13

No results posted yet for this study

Summary

To evaluate and compare the efficacy and safety of intralesional acyclovir versus intralesional vitamin D3 in the treatment of plantar warts

Conditions

  • Plantar Wart

Interventions

DRUG

Vitamin D

\- Vitamin D * The aqueous solution of vitamin D3 (cholecalciferol) will be used ampoule 200,000 IU/2 ML, * Using a 27-gauge syringe with the bevel facing upward, a maximum of 0.6 ml (60,000 IU) of vitamin D3 solution will be slowly injected into the base of the largest plantar wart (large warts \> 10 mm need multiple injections at different sites) * Treatment sessions will be performed at 3-week intervals for a maximum of 4 sessions

DRUG

acyclovir

-Acyclovir * Acyclovir vial (Zovirax® vial, 250mg, ) will be diluted with 3.5 ml saline to get approximately 70 mg /ml solution. * After sterilization of the skin, a 27-gauge syringe with the bevel facing upward will be inserted into the base of the largest plantar wart to slowly inject the solution * Treatment sessions will be performed at 2-week intervals for maximum of 5 sessions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • maha m mostafa, MD · Assuit University faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-10-31
Completion
2023-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05324904 on ClinicalTrials.gov